Yahoo
NasdaqGS - Delayed Quote USD

The Cooper Companies, Inc. (COO)

69.59 -1.05 (-1.49%)
At close: September 4 at 4:00:01 PM EDT
70.30 +0.71 (+1.02%)
After hours: September 4 at 7:30:01 PM EDT
Trade COO on Coinbase
Chart Range Bar
Loading chart for COO

What's happening with COO?

30m ago
Powered by Yahoo Scout

Cooper Companies (COO) is facing challenges with slower growth forecastsand muted demandin its core markets. Analysts maintain a cautious outlook despite recent stock performance improvements, highlighting subpar returns on investmentand regulatory risks.

Powered by Yahoo Scout
  • Previous Close 70.64
  • Open 69.82
  • Bid 63.98 x 200
  • Ask 75.41 x 200
  • Day's Range 69.51 - 70.48
  • 52 Week Range 58.89 - 89.83
  • Volume 1,956,954
  • Avg. Volume 2,347,425
  • Market Cap (intraday) 13.572B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 58.97
  • EPS (TTM) 1.18
  • Earnings Date Sep 9, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 26, 2023
  • 1y Target Est 81.50

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

www.coopercos.com

15,000

Full Time Employees

October 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

COO
15.09%
S&P 500 (^GSPC)
12.75%

1-Year Return

COO
2.34%
S&P 500 (^GSPC)
18.71%

3-Year Return

COO
23.67%
S&P 500 (^GSPC)
70.93%

5-Year Return

COO
38.92%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Analyst Insights

View More

Analyst Price Targets

66.00
81.50 Average
69.59 Current
92.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/13/2026
Analyst Citigroup
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 76 -> 80

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.57%

  • Return on Assets (ttm)

    2.52%

  • Return on Equity (ttm)

    2.85%

  • Revenue (ttm)

    4.23B

  • Net Income Avi to Common (ttm)

    235.8M

  • Diluted EPS (ttm)

    1.18

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    138.8M

  • Total Debt/Equity (mrq)

    33.09%

  • Levered Free Cash Flow (ttm)

    424.28M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: